While most people are now familiar with GLP-1 agonists they represent just one category of peptide-based therapies.

GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their ...

For patients with type 2 diabetes, a new study reinforces the importance of adhering to a healthy lifestyle even when taking a glucagon-like peptide-1 (GLP-1) receptor agonist. Patients who combined a ...

The health of state employees and MassHealth members “is on the line,” clinicians and patients warned on Tuesday, due to diminishing coverage for GLP-1 drugs for weight loss. The cries come against a ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including Ozempic, Wegovy and Zepbound ...

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...

Scientists have discovered natural GLP-1 in joint fluid, which could open up a new treatment option for arthritis.

As more people turn to prescription drugs for smaller weight-loss goals, one writer explores the pros and cons.